CVS’ Caremark to Pay $4.25M for Allegedly Failing to Reimburse Medicaid

CVS’s pharmacy benefit management company, Caremark, will pay the federal government and five states a total of $4.25 million to resolve allegations the company knowingly failed to reimburse Medicaid for prescriptions for patients who were also eligible for benefits under a Caremark health plan.

Advertisement

The original whistle-blower suit alleged Caremark had been erasing reimbursement claims from dual eligibles from its computer system, causing Medicaid to pick up the tab for prescription drugs that should have been covered by Caremark.

Under the terms of the settlement, the federal government will receive $2.31 million and Arkansas, California, Delaware, Louisiana and Massachusetts will share $1.94 million.

More Articles on Healthcare Lawsuits:

11 Kentucky Hospitals File Complaints Alleging HIX Exclusion
The Growth of Healthcare Fraud Qui Tam Lawsuits
Highmark and UPMC Continue to Battle Over Settlement

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.